Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ProPhase Labs (PRPH) Operating Income (2016 - 2025)

Historic Operating Income for ProPhase Labs (PRPH) over the last 16 years, with Q3 2025 value amounting to -$4.8 million.

  • ProPhase Labs' Operating Income rose 2648.15% to -$4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$29.6 million, marking a year-over-year increase of 831.94%. This contributed to the annual value of -$38.6 million for FY2024, which is 8204.05% down from last year.
  • Latest data reveals that ProPhase Labs reported Operating Income of -$4.8 million as of Q3 2025, which was up 2648.15% from -$3.9 million recorded in Q2 2025.
  • ProPhase Labs' Operating Income's 5-year high stood at $16.1 million during Q1 2022, with a 5-year trough of -$17.3 million in Q4 2024.
  • In the last 5 years, ProPhase Labs' Operating Income had a median value of -$3.9 million in 2025 and averaged -$2.0 million.
  • Within the past 5 years, the most significant YoY rise in ProPhase Labs' Operating Income was 189724.05% (2021), while the steepest drop was 255762.71% (2021).
  • ProPhase Labs' Operating Income (Quarter) stood at $13.7 million in 2021, then tumbled by 137.22% to -$5.1 million in 2022, then plummeted by 115.3% to -$11.0 million in 2023, then tumbled by 57.77% to -$17.3 million in 2024, then skyrocketed by 72.45% to -$4.8 million in 2025.
  • Its last three reported values are -$4.8 million in Q3 2025, -$3.9 million for Q2 2025, and -$3.7 million during Q1 2025.